Home›Search›Experimental Hematology and Oncology

Experimental Hematology and Oncology

BioMed Central Ltd · United Kingdom · Est. 2012

ISSN2162-3619eISSN2162-3619

SJR Q1✓ WOS SCIE✓ Scopus / SJR✓ DOAJ✓ Open Access

100

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (4 more)+22

Total100

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

122

days submission → published

measured · last 19 articles · accept 100d

weeks to publish · journal-reported

Fast · vs ~15 wk median

SJR Rank

Top 25% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei

4.126

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

1.692

Total Worksi

879

Total Citationsi

24,371

2yr Mean Citednessi

10.64

Open Impact Factor alternative

Aims & Scope

Subject areas: Hematology; Oncology; Cancer Research.

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published2012

FrequencyMonthly

StatusActive (last: 2026)

Total Publications879

Publisher OrgBioMed Central

OA Since2011

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

Review Time~6 weeks

Acceptance Rate—

OA LicenseCC BY, CC BY-NC-ND

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

CLOCKSSBritish LibraryLOCKSSPorticoPMC

Think.Check.Submit Compliance

thinkchecksubmit.org

10/12 · 83%

✅

Do you know the journal / publisher?

BioMed Central Ltd

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2162-3619 / 2162-3619

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ, PubMed

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

CLOCKSS, British Library, LOCKSS, Portico, PMC

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

946

2019

2020

2.7k

2021

108

3.7k

2022

105

3.4k

2023

123

2.5k

2024

141

1.5k

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Cancer ResearchQ1

HematologyQ1

OncologyQ1

Subject Classification

Web of Science Categories

HematologyOncology

Scopus Categories

HematologyCancer ResearchOncology

Research Topics (OpenAlex)

CAR-T cell therapy researchAcute Myeloid Leukemia ResearchCancer Immunotherapy and BiomarkersLymphoma Diagnosis and TreatmentImmune Cell Function and InteractionImmunotherapy and Immune ResponsesImmune cells in cancerChronic Lymphocytic Leukemia ResearchAcute Lymphoblastic Leukemia researchMultiple Myeloma Research and Treatments

Frequently asked questions about Experimental Hematology and Oncology

Is Experimental Hematology and Oncology a predatory journal?

PubScope has no integrity flags on record for Experimental Hematology and Oncology: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 100/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Experimental Hematology and Oncology?

Experimental Hematology and Oncology is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 10.64.

Is Experimental Hematology and Oncology indexed in Scopus and Web of Science?

Experimental Hematology and Oncology is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of Experimental Hematology and Oncology?